AKT1 and breast cancer: Previous studies have shown that miR-18a-5p is downregulated in breast cancer tissues and MCF-7 and MDA-MB-231 cells, and that its overexpression inhibits proliferation, migration, and activation of the PI3K/AKT pathway [36].